Advertisement
Advertisement

NYXH

NYXH logo

Nyxoah SA

7.86
USD
-0.13
-1.63%
Dec 18, 15:22 UTC -5
Open

Nyxoah SA Profile

About

Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium.

Info & Links

CEO

Olivier Taelman

Headquarters

RUE EDOUARD BELIN 12
MONT-SAINT-GUIBERT, C9 1435, BELGIUM

Auditor

EY R¿viseurs d¿Entreprises / EY Bedrijfsrevisoren SRL/BV

Share holders

--

Employees

147

Nyxoah SA Statistics

Valuation Measures

Market Capitalization2

--

Enterprise Value

--

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

62.10%

Operating Margin(ttm)

-1043.93%

Profit Margin(ttm)

-1155.74%

Return on Equity(ttm)

-51.68%

Return on Invested Capital(ttm)

-45.44%

Return on Assets(ttm)

-40.11%

Income Statement

Revenue(ttm)

5.51M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

3.40M

EBITDA(ttm)3

-52.80M

Net Income Available to Common(ttm)

-57.56M

Diluted EPS(ttm)

-1.87

Share Statistics

Beta (5Y Monthly)

1.35

52-Week Change

60.41%

S&P 500 52-Week Change

25.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

78.05M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

25.65M

Total Debt/Equity(mrq)

22.28%

Current Ratio(mrq)

5.28%

Quick Ratio(mrq)

4.95%

Book Value Per Share(mrq)

3.35

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.18

Free Cash Flow(ytd)

-41.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement